LLY: Obesity treatment portfolio expands with new therapies, digital access, and strong cost-effectiveness data
A broad obesity portfolio is being developed to address diverse patient needs, with foundational and new therapies expanding access and improving outcomes. Cost-effectiveness data and digital initiatives are driving employer engagement and consumer orientation, while international launches and pipe…